Novel screening assay to identify and evaluate drugs that target Familial and Sporadic Amyotrophic Lateral Scelrosis
- 详细技术说明
- In vitro cell-based assay thatenables investigating molecular disease mechanisms and evaluating potentialtherapies for Sporadic Amyotrophic Lateral Sclerosis (ALS).
- *Abstract
-
This is an in vitro cell-based assay that enables investigating molecular disease mechanisms and evaluating potential therapies for Sporadic Amyotrophic Lateral Sclerosis (ALS). This assay utilizes human derived cells from individuals with the disease.
- *Inquiry
- Margaret Barkett, Ph.D.The Research Institute atNationwide Children's HospitalOffice of TechnologyCommercialization700 Children's DriveColumbus OH 43205T: 614 355-2957 F: 614722-2716Margaret.Barkett@nationwidechildrens.org
- *IP Issue Date
- None
- *IP Type
- Other Patent
- 国家
- Not Available
- 申请号码
- None
- 国家/地区
- 美国
欲了解更多信息，请点击 这里
